BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker

-Brain diagnostics innovator BrainScope announced  a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s ...

September 20, 2023 | Wednesday | News
Catalent Announces Governance Enhancements and New Initiatives to Drive Value

Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...

August 30, 2023 | Wednesday | News
Cellares Raises $255M Series C to Launch Pioneering Cell Therapy Smart Factory

Series C is led by Koch Disruptive Technologies and includes Bristol Myers Squibb, DFJ Growth, Willett Advisors and existing investors Eclipse, Dech...

August 24, 2023 | Thursday | News
Pyxis Oncology Successfully Completes Acquisition of Apexigen

Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as a leader in next-generation, end-to...

August 24, 2023 | Thursday | News
Bruker to Acquire PhenomeX in All-Cash Deal

Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire Pheno...

August 18, 2023 | Friday | News
"Illumina Reports 8% Sequential Revenue Growth in Q2, NovaSeq X Shipments Exceed Expectations," says Interim CEO Charles Dadswell

Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments i...

August 10, 2023 | Thursday | Company results
Emergent's 2023 Milestones Bolster America's Preparedness for Public Health Challenges, Securing Financial Resilience, Declares CEO Haywood Miller

Reports Q2 2023 total revenues of $338M, above the prior guidance range, net loss of $261M and adjusted EBITDA of $56M Updates FY 2023 guidance and prov...

August 09, 2023 | Wednesday | Company results
Gilead's Remarkable Q2 Performance: 11% Year-Over-Year Growth Fueled by Diverse Therapeutic Portfolio, Positive Regulatory Advances, and Promising Pipeline, Declares CEO Daniel O’Day

Product Sales Excluding Veklury Increased 11% Year-Over-Year to $6.3 billion Biktarvy Sales Increased 17% Year-Over-Year to $3.0 billion Oncology Sales...

August 07, 2023 | Monday | Company results
Syneos Health Stockholders Approve Agreement with Private Investment Consortium

Syneos Health, Inc. (Nasdaq: SYNH) (“Syneos Health” or the “Company”), a leading fully integrated biopharmaceutical solutions organ...

August 03, 2023 | Thursday | News
Biogen to Acquire Reata Pharmaceuticals

SKYCLARYS® recently approved in US as the only treatment indicated for patients with Friedreich’s ataxia   Proposed acquisition ...

July 31, 2023 | Monday | News
SomaLogic to Announce Second Quarter 2023 Financial Results on August 14, 2023

Those interested in listening to the conference call should register online here. Participants are encouraged to register more than 15 minutes before the s...

July 25, 2023 | Tuesday | News
Bio-Rad Announces New Share Repurchase Program

“The new share buyback authorization is consistent with our disciplined approach and demonstrates our continued commitment to using this tool as part...

July 21, 2023 | Friday | News
Modi Ventures Launches $32M Fund to Disrupt Health and Medicine Tech

Modi Ventures, a newly launched venture partnership investing in fund managers and founders building companies shaping the future of humanity, today announ...

July 17, 2023 | Monday | News
Thermo Fisher Scientific Declares Quarterly Dividend

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make ...

July 14, 2023 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in